Study probes gut microbiome, FMT, and obesity in cats: full analysis

A new feline obesity study is pointing veterinary attention back to the gut microbiome, but with a fairly restrained takeaway: there may be measurable microbial and metabolic differences between cats with different body conditions, yet fecal microbiota transplantation is still far from a practice-ready obesity intervention. In a May 2026 Veterinary Sciences paper, investigators used a multi-omics approach to compare obese, normal, and lean cats, then tested FMT using feces from obese or lean donors. Their topline finding was nuanced: body condition was associated with certain taxa and metabolic features, but not with major shifts in overall microbial diversity or community structure. (mdpi.com)

That nuance fits the broader feline microbiome literature. Earlier work has shown that obesity in cats can be associated with microbiome changes, but the signal has not been uniform across studies. A 2024 MDPI study on metabolic health and obesity status in cats concluded that obesity had only minimal impact on fecal microbiota overall, while an older British Journal of Nutrition study suggested obesity, neutering, and energy restriction may all influence fecal microbial patterns. At the same time, multiple studies have found diet to be one of the strongest determinants of the feline gut microbiome, complicating efforts to isolate obesity-specific effects. (mdpi.com)

In the new paper, the researchers enrolled 24 cats for the observational arm and grouped them as obese, normal, or lean. They paired microbiota profiling with serum metabolomics, then ran a second experiment in which fecal microbiota from obese or lean donors was transplanted into recipient cats. According to the article summary indexed by MDPI, obese cats showed enrichment of Coriobacteriaceae and Collinsella, whereas normal-weight cats had higher abundances of Enterobacteriaceae-related taxa. The study did not find statistically significant differences in overall diversity or community structure among groups, which tempers any simple claim that feline obesity maps cleanly onto a distinct microbiome state. (mdpi.com)

Those taxa are biologically interesting, but not straightforward. Collinsella and related Coriobacteriaceae have been linked in prior cat and broader microbiome research to lipid handling, bile acid metabolism, and carbohydrate fermentation, but their meaning can vary by diet, host species, and disease context. In healthy cats, Collinsella abundance has also been associated with diet category, including raw-fed animals, which underscores how difficult it is to separate body condition from feeding patterns and other environmental variables. (mdpi.com)

Industry and expert commentary specific to this paper appears limited so far, which is not unusual for an early-stage companion animal microbiome study. But adjacent literature offers a cautious frame. A 2024 study on cats treated with metronidazole noted that feline FMT research remains limited, even as interest grows. A 2023 Veterinary Sciences study of cats with chronic digestive issues found that FMT responses varied with clinical signs and diet, and a 2024 review concluded that while FMT can modify feline gut microbiota, durable remodeling may be difficult to achieve. (mdpi.com)

Why it matters: For veterinary teams, this study is most useful as a signal about where the science is heading, not as a reason to change obesity management today. The findings support continued interest in the microbiome-metabolism axis in cats, especially as obesity remains tied to insulin resistance, dyslipidemia, and other metabolic disturbances. But they also reinforce that microbiome-based interventions in cats are still exploratory, with limited standardization around donor screening, protocols, durability, and clinically meaningful endpoints. For now, evidence-backed care still centers on nutritional assessment, calorie control, body condition monitoring, and pet parent adherence, with microbiome tools remaining largely investigational in this setting. (mdpi.com)

What to watch: The next important step will be whether researchers can connect microbial shifts to hard clinical outcomes, such as sustained weight loss, insulin sensitivity, lipid changes, or reduced relapse after intervention, and whether those effects hold up in larger, controlled feline studies. It will also be worth watching for more detail on the metabolomics findings from this paper, as well as whether future work compares FMT directly with dietary strategies that may have stronger and more reproducible effects on the feline gut microbiome. (mdpi.com)